Global Vaccines Market Research Report 2021

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Vaccines can be divided into recombinant vaccines, viral vaccines, polysaccharide vaccines and others. Recombinant vaccines and viral vaccines contain many kinds of vaccines, and the demand is larger than others kinds. But with the development of new technologies, more and more new types of vaccines will be popularized. The scope for disease prevention will be enlarged .The demand of other kinds is also increasing.

The global Vaccines market was valued at US$ 39670 million in 2019 and is expected to reach US$ 58340 million by the end of 2026, growing at a CAGR of 5.6% during 2021-2026.
This report focuses on Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Segment by Application
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles Vaccine
Hepatitis A
Live Attenuated Influenza Vaccine
Polio Vaccine
Rabies Vaccine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan